FDA ap­proves first drug for Prad­er-Willi syn­drome, to tamp down in­sa­tiable hunger symp­toms

The FDA on Wednes­day ap­proved Soleno Ther­a­peu­tics’ new drug de­signed to treat the worst symp­tom of a de­bil­i­tat­ing rare dis­ease known as Prad­er-Willi syn­drome. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER